☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Erythrodermic Psoriasis
AbbVie's Skyrizi (risankizumab) Receives Japanese Ministry of Health- Labour and Welfare (MHLW) Approval to Treat Plaque Psoriasis...
March 26, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.